Rodano, Italy

Ettore Negri

This inventor holds 1 USPTO granted patent. Top assignee: Antibioticos. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ettore Negri. Retrieved from https://idiyas.com/inventor/ettore-negri-9pvan0bb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ettore Negri: Innovator in Pharmaceutical Chemistry

Introduction

Ettore Negri is a notable inventor based in Rodano, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of stable crystalline forms of important compounds.

Latest Patents

Ettore Negri holds a patent for "Crystalline irinotecan hydrochloride and methods for its preparation." This patent discloses a crystalline form of irinotecan hydrochloride and processes for its preparation from crude irinotecan hydrochloride or another polymorphic form of irinotecan. The crystalline form is particularly suitable for industrial use, as it is easily filtered and possesses characteristics of high stability and purity. He has 1 patent to his name.

Career Highlights

Ettore Negri is associated with Antibioticos S.p.a., where he applies his expertise in pharmaceutical development. His work focuses on enhancing the quality and stability of pharmaceutical compounds, which is crucial for their effectiveness and safety.

Collaborations

Throughout his career, Ettore has collaborated with notable colleagues such as Giovanni Pozzi and Paolo Ghetti. These collaborations have contributed to advancements in the pharmaceutical industry.

Conclusion

Ettore Negri's innovative work in the field of pharmaceutical chemistry, particularly with his patent on crystalline irinotecan hydrochloride, showcases his commitment to improving drug formulations. His contributions are vital for the advancement of pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…